Now, Cleveland Clinic researchers may have figured out which patients have the best odds of success. Women who take Wegovy to treat obesity have the greatest likelihood of achieving 10% or more weight ...

THE HSE has splashed out over €200million on weight-loss jabs in less than three years. And it’s emerged that 80,000 patients ...

Just under €212m was spent on Ozempic and Saxenda under the medical card, Drugs Payment Scheme and Long-Term Illness schemes in two years and eight months ...

Share on Pinterest Experts say people should expect to be on weight loss medications for a long period of time. NurPhoto/Getty Images Researchers report that more than half of people on weight loss ...

The growing list of insurers dropping coverage for costly GLP-1 weight loss drugs leaves patients to bear even higher out-of-pocket expenses while still struggling to ...

Saxenda (liraglutide) is a GLP-1 agonist injection pen medication used to support long-term weight loss in adults with obesity, adults with overweight and weight-related health issues, and certain ...

Generic Saxenda ® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market. This approval and launch add to Teva’s ...